Medtronic Completes MiniMed Exchange Offer, Fully Divests MiniMed Group (MDT)
gurufocus.com · 2026-10-14
On October 14, 2026, Medtronic PLC (NYSE: MDT) finalized its exchange offer for MiniMed Group (MMED), completing its divestment from the diabetes-focused busine
TickrTrends take: Medtronic's completion of the MiniMed Exchange Offer represents a significant portfolio restructuring that removes a diabetes care business from the company's operations. TickrTrends currently rates MDT as undervalued within the Healthcare sector, suggesting the market may not be fully pricing in the strategic implications of this divestiture. Investors focused on valuation should monitor how the company redeploys capital from this transaction and whether the streamlined business mix affects MDT's margin profile and growth trajectory going forward.
Read the full story at gurufocus.com →
Is MDT undervalued? See TickrTrends' fair value analysis →